Company

Angiogenex Inc

Biotechnology Research New York, Ny, United States 4 employees

Employees: 4
Contacts: 2
Emails: 2
Phones: 1

angiogenex.com LinkedIn Crunchbase

Angiogenex Inc Overview

Headquarters: New York, Ny, United States
Phone Number: Available in AeroLeads
Website: angiogenex.com
Industry: Biotechnology Research
Employees: 4
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

SynsoryBio

About Angiogenex Inc

AngioGenex is a biopharmaceutical company committed to the discovery and development of Id protein inhibitors to address unmet medical needs in oncology and ophthalmology. AngioGenex and its collaborators, including Robert Benezra, Ph.D., and The Robert Benezra Lab at Sloan Kettering Institute, have assembled key platform enabling technologies and tools that allow for the identification of specific and potent small molecule binders of Id. Id proteins have been shown to play a key role in mediating the pathogenesis of certain cancers and diseases of the eye. AngioGenex’s lead development candidate is AGX-A, a novel small molecule being investigated for the treatment of cholangiocarcinoma (a form of liver cancer) and age-related macular degeneration (AMD). AngioGenex is headquartered in New York, NY.

Angiogenex Inc Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage
Phone contacts: 1; 33.3% coverage

Angiogenex Inc Org Chart

Sample employees and titles

Name	Title	Location	Contact
Michael Strage	General Counsel at Angiogenex, Inc.	New York, United States	Email
Michael Aronstein	Investment Management	Greenwich, Connecticut, United States	View
Robert Dickey	Life Sciences CFO and Board Member	Philadelphia, Pennsylvania, United States	Email Phone